Experimental Stroke Drug Slows Bleeding but Doesn’t Improve Recovery
Hemorrhagic Stroke Treatment: A Step Forward, But Recovery Remains Complex A recent global clinical trial, involving 93 hospitals across six countries, has revealed a nuanced picture in the treatment of hemorrhagic stroke. While an experimental drug, recombinant factor VIIa, demonstrably slowed brain bleeding, it did not translate into improved long-term functional recovery for patients. The … Read more